JP2017500305A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017500305A5 JP2017500305A5 JP2016538101A JP2016538101A JP2017500305A5 JP 2017500305 A5 JP2017500305 A5 JP 2017500305A5 JP 2016538101 A JP2016538101 A JP 2016538101A JP 2016538101 A JP2016538101 A JP 2016538101A JP 2017500305 A5 JP2017500305 A5 JP 2017500305A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- seq
- tarp
- composition according
- overlapping
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361915948P | 2013-12-13 | 2013-12-13 | |
| US61/915,948 | 2013-12-13 | ||
| PCT/US2014/070144 WO2015089469A1 (en) | 2013-12-13 | 2014-12-12 | Multi-epitope tarp peptide vaccine and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017500305A JP2017500305A (ja) | 2017-01-05 |
| JP2017500305A5 true JP2017500305A5 (enExample) | 2018-01-18 |
| JP6758185B2 JP6758185B2 (ja) | 2020-09-23 |
Family
ID=52432905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538101A Active JP6758185B2 (ja) | 2013-12-13 | 2014-12-12 | マルチエピトープｔａｒｐペプチドワクチンおよびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10286050B2 (enExample) |
| EP (1) | EP3079716B1 (enExample) |
| JP (1) | JP6758185B2 (enExample) |
| AU (1) | AU2014361788B2 (enExample) |
| CA (1) | CA2932248C (enExample) |
| DK (1) | DK3079716T3 (enExample) |
| WO (1) | WO2015089469A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11266726B2 (en) | 2015-10-30 | 2022-03-08 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Compositions and methods for the treatment of HER2-expressing solid tumors |
| AU2023364999A1 (en) * | 2022-10-17 | 2025-05-22 | Pds Biotechnology Corporation | Novel non-HLA restricted T cell TCR gamma alternate reading frame protein (TARP) compositions and uses thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5270202A (en) | 1989-11-03 | 1993-12-14 | Syamal Raychaudhuri | Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen |
| ATE166578T1 (de) | 1991-07-25 | 1998-06-15 | Idec Pharma Corp | Anregung von antworten zytotoxischer t- lymphozyten |
| US5709860A (en) | 1991-07-25 | 1998-01-20 | Idec Pharmaceuticals Corporation | Induction of cytotoxic T-lymphocyte responses |
| US5643578A (en) | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
| US5662907A (en) | 1992-08-07 | 1997-09-02 | Cytel Corporation | Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes |
| DE69332485T2 (de) | 1992-08-11 | 2003-11-13 | The President And Fellows Of Harvard College, Cambridge | Immunmodulierende peptide |
| US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| EP1167378B1 (en) | 1994-07-15 | 2011-05-11 | University of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| AU738513B2 (en) | 1997-02-28 | 2001-09-20 | University Of Iowa Research Foundation, The | Use of nucleic acids containing unmethylated CpG dinucleotide in the treatment of LPS-associated disorders |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| EP1003531B1 (en) | 1997-05-20 | 2007-08-22 | Ottawa Health Research Institute | Processes for preparing nucleic acid constructs |
| US6218371B1 (en) | 1998-04-03 | 2001-04-17 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| IL147507A0 (en) | 1999-07-13 | 2002-08-14 | Us Gov Health & Human Serv | T-cell receptor y and uses thereof |
| SE9903031D0 (sv) * | 1999-08-27 | 1999-08-27 | Eurodiagnostica Ab | Peptide mixture and vaccine against a chronic viral infection |
| AU2003245729A1 (en) * | 2002-06-27 | 2004-01-19 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for modulating a cytotoxic t lymphocyte immune response |
| US7541035B2 (en) | 2003-06-05 | 2009-06-02 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Immunogenic peptides for the treatment of prostate and breast cancer |
| CA2654271A1 (en) | 2006-06-28 | 2008-01-03 | Statens Serum Institut | Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails |
-
2014
- 2014-12-12 DK DK14831120.2T patent/DK3079716T3/da active
- 2014-12-12 WO PCT/US2014/070144 patent/WO2015089469A1/en not_active Ceased
- 2014-12-12 US US15/102,996 patent/US10286050B2/en active Active
- 2014-12-12 CA CA2932248A patent/CA2932248C/en active Active
- 2014-12-12 JP JP2016538101A patent/JP6758185B2/ja active Active
- 2014-12-12 EP EP14831120.2A patent/EP3079716B1/en active Active
- 2014-12-12 AU AU2014361788A patent/AU2014361788B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102308798B1 (ko) | 다양한 암의 면역요법 치료에서의 사용을 위한 펩티드, 펩티드의 조합 및 골격 | |
| CY1122235T1 (el) | Καινοτομος ανοσοθεραπεια εναντι διαφορων ογκων συμπεριλαμβανομενου του γαστρεντερικου και του γαστρικου καρκινου | |
| JP2018510215A5 (enExample) | ||
| JP2018509936A5 (enExample) | ||
| KR20180085725A (ko) | 다양한 암에 대한 면역요법에서의 사용을 위한 신규 펩티드 및 펩티드의 조합 | |
| KR20180111998A (ko) | 비호지킨 림프종 및 기타 암에 대한 면역요법에서의 사용을 위한 신규 펩티드 및 펩티드의 조합 | |
| EA201071297A1 (ru) | Новые и действенные пептиды мнс ii класса, полученные из сурвивина | |
| HK1244666A1 (zh) | 用於肺癌(包括非小细胞肺癌和其他癌)免疫治疗的新型肽和肽组合物 | |
| US20250312428A1 (en) | Heterologous Prime Boost Vaccine | |
| PE20181897A1 (es) | Inmunoterapia contra el melanoma y otros tipos de cancer | |
| JP6406647B2 (ja) | 細胞性免疫誘導ワクチン | |
| JP2016511221A5 (enExample) | ||
| JP2012102105A5 (enExample) | ||
| JP2014519311A5 (enExample) | ||
| EP2528937A4 (en) | MODIFIED MELK-PEPTIDES AND VACCINES CONTAINING THEREOF | |
| JP2015529219A5 (enExample) | ||
| JP2018528960A5 (enExample) | ||
| RU2014109137A (ru) | Пептиды mphosph1 и вакцины, включающие их | |
| JP2017500305A5 (enExample) | ||
| JP2014506114A5 (enExample) | ||
| RU2015126849A (ru) | Пептиды sema5в и вакцины, содержащие эти пептиды | |
| JP2014504146A5 (enExample) | ||
| NZ746513A (en) | Novel peptides and combination of peptides for use in immunotherapy against various tumors | |
| MY194244A (en) | Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc | |
| MY193910A (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc |